The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Neonatal Diagnosis and Treatment of Menkes Disease
Open accessAbstract
BACKGROUND: Menkes disease is a fatal neurodegenerative disorder of infancy caused by diverse mutations in a copper-transport gene, ATP7A. Early treatment with copper injections may prevent death and illness, but presymptomatic detection is hindered by the inadequate sensitivity and specificity of diagnostic tests. Exploiting the deficiency of a copper enzyme, dopamine-beta-hydroxylase, we prospectively evaluated the diagnostic usefulness of plasma neurochemical levels, assessed the clinical effect of early detection, and investigated the molecular bases for treatment outcomes. METHODS: Between May 1997 and July 2005, we measured plasma dopamine, norepinephrine, dihydroxyphenylacetic acid, and dihydroxyphenylglycol in 81 infants at risk. In 12 newborns who met the eligibility criteria and began copper-replacement therapy within 22 days after birth, we tracked survival and neurodevelopment longitudinally for 1.5 to 8 years. We characterized ATP7A mutations using yeast complementation, reverse-transcriptase-polymerase-chain-reaction analysis, and immunohistochemical analysis. RESULTS: Of 81 infants at risk, 46 had abnormal neurochemical findings indicating low dopamine-beta-hydroxylase activity. On the basis of longitudinal follow-up, patients were classified as affected or unaffected by Menkes disease, and the neurochemical profiles were shown to have high sensitivity and specificity for detecting disease. Among 12 newborns with positive screening tests who were treated early with copper, survival at a median follow-up of 4.6 years was 92%, as compared with 13% at a median follow-up of 1.8 years for a historical control group of 15 late-diagnosis and late-treatment patients. Two of the 12 patients had normal neurodevelopment and brain myelination; 1 of these patients had a mutation that complemented a Saccharomyces cerevisiae copper-transport mutation, indicating partial ATPase activity, and the other had a mutation that allowed some correct ATP7A splicing. CONCLUSIONS: Neonatal diagnosis of Menkes disease by plasma neurochemical measurements and early treatment with copper may improve clinical outcomes. Affected newborns who have mutations that do not completely abrogate ATP7A function may be especially responsive to early copper treatment. (ClinicalTrials.gov number, NCT00001262.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional Characterization of the S. cerevisiae Genome by Gene Deletion and Parallel Analysis
Winzeler, E. A., Shoemaker, D. D., Astromoff, A., Liang, H., Anderson, K., Andre, B., Bangham, R., Benito, R., Boeke, J. D., Bussey, H., et al. (1999) · Science · doi:10.1126/science.285.5429.901 · Cited by 3,953
Vulpe, C., Levinson, B., Whitney, S., Packman, S., & Gitschier, J. (1993) · Nature Genetics · doi:10.1038/ng0193-7 · Cited by 1,418
The Denver II: A Major Revision and Restandardization of the Denver Developmental Screening Test
Frankenburg, W. K., Dodds, J., Archer, P., Shapiro, H., & Bresnick, B. (1992) · Pediatrics · doi:10.1542/peds.89.1.91 · Cited by 1,111
Chelly, J., Tümer, Z., Tønnesen, T., Petterson, A., Ishikawa-Brush, Y., Tommerup, N., Horn, N., & Monaco, A. P. (1993) · Nature Genetics · doi:10.1038/ng0193-14 · Cited by 726
Isolation of a partial candidate gene for Menkes disease by positional cloning
Mercer, J. F. B., Livingston, J., Hall, B., Paynter, J. A., Begy, C., Chandrasekharappa, S., Lockhart, P., Grimes, A., Bhave, M., Siemieniak, D., et al. (1993) · Nature Genetics · doi:10.1038/ng0193-20 · Cited by 696
Schulze, A., Lindner, M., Kohlmüller, D., Olgemöller, K., Mayatepek, E., & Hoffmann, G. F. (2003) · Pediatrics · doi:10.1542/peds.111.6.1399 · Cited by 519
Primary defect in copper transport underlies mottled mutants in the mouse
Hunt, D. M. (1974) · Nature · doi:10.1038/249852a0 · Cited by 320
NMDA Receptor Activation Mediates Copper Homeostasis in Hippocampal Neurons
Schlief, M. L., Craig, A. M., & Gitlin, J. D. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3699-04.2005 · Cited by 290
Kaler, S. G., Gallo, L. K., Proud, V. K., Percy, A. K., Mark, Y., Segal, N. A., Goldstein, D. S., Holmes, C. S., & Gahl, W. A. (1994) · Nature Genetics · doi:10.1038/ng1094-195 · Cited by 264
Self-citationRole of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity
Schlief, M. L., West, T., Craig, A. M., Holtzman, D. M., & Gitlin, J. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605390103 · Cited by 184
Fu, D., Beeler, T. J., & Dunn, T. M. (1995) · Yeast · doi:10.1002/yea.320110310 · Cited by 169
Lockitch, G., Halstead, A. C., Wadsworth, L. D., Quigley, G., Reston, L., & Jacobson, B. E. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.8.1625 · Cited by 138
Plasma and cerebrospinal fluid neurochemical pattern in Menkes disease
Kaler, S. G., Goldstein, D. S., Holmes, C. S., Salerno, J. A., & Gahl, W. A. (1993) · Annals of Neurology · doi:10.1002/ana.410330206 · Cited by 108
Self-citationEarly copper-histidine treatment for Menkes disease
Tümer, Z., Horn, N., Tønnesen, T., Christodoulou, J., Clarke, J. T. R., & Sarkar, B. (1996) · Nature Genetics · doi:10.1038/ng0196-11 · Cited by 97
Early copper therapy in classic Menkes disease patients with a novel splicing mutation
Kaler, S. G., Buist, N. R. M., Holmes, C. S., Goldstein, D. S., Miller, R. C., & Gahl, W. A. (1995) · Annals of Neurology · doi:10.1002/ana.410380613 · Cited by 74
Self-citationAmbrosini, L., & Mercer, J. F. B. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1547 · Cited by 72
Functional copper transport explains neurologic sparing in Occipital Horn syndrome
Tang, J., Robertson, S. P., Lem, K. E., Godwin, S. C., & Kaler, S. G. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000245578.94312.1e · Cited by 63
Self-citationDownregulation of myelination, energy, and translational genes in Menkes disease brain
Liu, P.-C., Chen, Y., Centeno, J. A., Quezado, M., Lem, K. E., & Kaler, S. G. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.04.007 · Cited by 53
Self-citationMenkes Kinky Hair Syndrome: Is it a treatable disorder?
Garnica, A. D., Frías, J. L., & Rennert, O. M. (1977) · Clinical Genetics · doi:10.1111/j.1399-0004.1977.tb01294.x · Cited by 47
Difficulties in the Neonatal Diagnosis of Menkes' Kinky Hair Syndrome—Trichopoliodystrophy
Gunn, T. R., Macfarlane, S., & Phillips, L. (1984) · Clinical Pediatrics · doi:10.1177/000992288402300915 · Cited by 25
Hao, C., March, R. E., Croley, T. R., Chen, S., Legault, M. G., & Yang, P. (2002) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.589 · Cited by 14
Cited by
Copper homeostasis and cuproptosis in health and disease
Chen, L., Min, J., & Wang, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01229-y · Cited by 1,493
Wilson's disease and other neurological copper disorders
Bandmann, O., Weiss, K. H., & Kaler, S. G. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70190-5 · Cited by 1,036
Self-citationCopper in diseases and treatments, and copper‐based anticancer strategies
Tisato, F., Marzano, C., Porchia, M., Pellei, M., & Santini, C. (2010) · Medicinal Research Reviews · doi:10.1002/med.20174 · Cited by 797
ATP7A-related copper transport diseases—emerging concepts and future trends
Kaler, S. G. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.180 · Cited by 630
Self-citationMetabolism and functions of copper in brain
Scheiber, I. F., Mercer, J. F. B., & Dringen, R. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.01.002 · Cited by 506
Metadata
- Authors
- Kaler, S. G., Holmes, C. S., Goldstein, D. S., Tang, J., Godwin, S. C., Donsante, A., Liew, C. J., Sato, S., & Patronas, N.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-02-07
- Volume
- 358
- Issue
- 6
- Pages
- 605-614
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2010103693
- Cited by
- 323
- References
- 21
- FWCI
- 20.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.